Overview
- 24 inspections across 23 sites are on record.
- 24 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-11.
At a glance
Inspections
24
Sites
23
Observations
24
Career since
Oct 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Trifluent Pharma LLC | 11 Jun 2026 | Human Drugs | View 483 → |
| RB Health Manufacturing (US), LLC | 13 Mar 2026 | Human Drugs | |
| BioChroma Analytical Labs, LLC. | 23 Feb 2026 | Human Drugs | |
| Specialty Formulations & Manufacturing, LLC | 12 Sep 2025 | Human Drugs | View 483 → |
| Dhaliwal Labs South LLC | 26 Jun 2025 | Human Drugs | View 483 → |
Sites inspected
Trifluent Pharma LLCSan Antonio, United States1 insp.
RB Health Manufacturing (US), LLCSalt Lake City, United States1 insp.
BioChroma Analytical Labs, LLC.Dallas, United States1 insp.
Specialty Formulations & Manufacturing, LLCPhoenix, United States1 insp.
Dhaliwal Labs South LLCDallas, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Shelby N Turner8 shared
Timothy H Vo5 shared
Shanna N Purdy4 shared
Margaret M Annes3 shared
Ariel Cruz Figueroa2 shared
Nicole E Knowlton2 shared
Clinton J Lott1 shared
Adam R Cooke1 shared
Gretchen M Laws1 shared
Full investigator report
Get the verbatim findings behind Kevin T Nguyen's 24 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site